No business profile yet.
Size Bain Capital Specialty Finance (BCSF) is a United States Financials company (Financial Conglomerates) with a market value of $684M, the 2477th largest of 3,085 United States companies the cockpit tracks. Shares closed at $10.54 on 18 Nov 2026.
Performance Over six months the shares fell 20.4%, against +0.7% for the median peer and -2.2% for the United States market (cap-weighted) — 2nd lowest of 19 in its peer set.
Growth Revenue fell 8.2% over the last twelve months (peer median +4.0%); the operating margin is 68.0% (peer median 14.5%).
Valuation It trades at 7.8× forward earnings against a peer median of 13.5× (2nd cheapest of 6).
Credit Bain Capital Specialty Finance has 2 bonds outstanding ($700M), rated Baa3 by the agencies and trading like BB- at a weighted spread of 270 bp.
Short interest Short interest is 1.9% of the free float (30 Oct 2026).
Next results Next results expected around 2 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $215M | $239M | $285M | $253M | $237M |
| Revenue growth | — | -16% | +12% | +7% | — |
| Gross profit | $166M | $184M | $220M | $192M | $183M |
| EBITDA | $146M | $181M | $199M | $208M | $158M |
| Net income | $61.9M | $98.8M | $119M | $123M | $105M |
| Free cash flow | $40.3M | $127M | $113M | $126M | $114M |
| Capital expenditure | $0 | $0 | $0 | $0 | $0 |
| Total debt | $1.30B | $1.47B | $1.39B | $1.26B | $1.39B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | BCSF | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +4.0% | -0.1% | 5th highest of 21 |
| 6-month return | -20.4% | +0.7% | 2nd lowest of 19 |
| Distance from 52-week high | -28.3% | -10.1% | 5th lowest of 21 |
| Revenue growth (TTM) | -8.2% | +4.0% | 2nd lowest of 11 |
| Operating margin | 68.0% | 14.5% | 3rd highest of 11 |
| Forward P/E | 7.8× | 13.5× | 2nd cheapest of 6 |
| Bond spread | 270 bp | n/a | — |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Bain Capital Specialty Finance BCSF | United States | $684M | -20% | -8% | 68% | 7.8× | n/a | n/a |
| Svolder SVOL-A.ST | Sweden | $667M | +42% | +1,360% | 90% | n/a | n/a | n/a |
| Drugs Made In America Acquisition II DMII | United States | $652M | +2% | n/a | n/a | n/a | n/a | n/a |
| Senvest Capital SEC.TO | Canada | $745M | +21% | -17% | 453% | n/a | n/a | n/a |
| Metalla Royalty & Streaming MTA.V | Canada | $616M | +2% | +56% | 17% | 47.9× | n/a | n/a |
| Patrizia PAT.DE | Germany | $765M | +6% | +19% | 15% | 31.4× | n/a | n/a |
| EQV Ventures Acquisition Corp. II EVAC | United States | $606M | +2% | n/a | n/a | n/a | n/a | n/a |
| Bain Capital GSS Investment BCSS | United States | $604M | +2% | n/a | n/a | n/a | n/a | n/a |
| Cantor Equity Partners IV CEPF | United States | $591M | 0% | n/a | n/a | n/a | n/a | n/a |
| OIO OIO | United States | $584M | -5% | -4% | -85% | n/a | n/a | n/a |
| Churchill Capital Corp XII CXII | United States | $577M | n/a | n/a | n/a | n/a | n/a | n/a |
| MidCap Financial Investment MFIC | United States | $822M | -7% | -4% | 19% | 7.7× | n/a | n/a |
| Luyin Investment 600784.SS | China | $563M | -28% | +4% | 5% | n/a | n/a | n/a |
| RMR RMR | United States | $546M | -14% | -8% | 10% | 10.1× | n/a | n/a |
| Monex 8698.T | Japan | $884M | -14% | +4% | 14% | 13.5× | n/a | n/a |
| American Exceptionalism Acquisition AEXA | United States | $526M | -7% | n/a | n/a | n/a | n/a | n/a |
| KB Balhae Infrastructure Fund 415640.KS | South Korea | $911M | +1% | n/a | n/a | n/a | n/a | n/a |
| Tangen Industrikapital TANGEN-B.ST | Sweden | $508M | n/a | +37% | 8% | n/a | n/a | n/a |
| Acceler8 Ventures AC8.L | United Kingdom | $507M | -2% | n/a | n/a | n/a | n/a | n/a |
| L1 Gold Fund LGF.AX | Australia | $926M | +11% | n/a | n/a | n/a | n/a | n/a |
| New America Acquisition I NWAX | United States | $500M | 0% | n/a | n/a | n/a | n/a | n/a |
Bain Capital Specialty Finance has 2 bonds outstanding with $700M face value. The agencies rate it Baa3; its bonds trade like BB-. Weighted yield 7.35%, a spread of 270 bp over government bonds.